Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis
Yu Kataoka, Peter J. Psaltis, Thomas Hucko, Julie Butters et al.
Citations
3 citations
Journal
European Journal of Preventive Cardiology
Topics
Lipoproteins and Cardiovascular Health
Field-Weighted Citation Impact (FWCI)
6.02
article
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis
Yu Kataoka, Peter J. Psaltis, Thomas Hucko, Julie Butters, G. Di Giovanni, Masashi Fujino, Stephen James Nicholls, Adam J. Nelson, Rishi Puri, Steven E. Nissen
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
European Journal of Preventive Cardiology
Institutions
Cleveland Clinic (US), Amgen (United States) (US), National Cerebral and Cardiovascular Center (JP), South Australian Health and Medical Research Institute (AU), Center for Clinical Research (United States) (US), Monash University (AU), The University of Adelaide (AU)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Impact of evolocumab on plaque phenotypic changes in patients with acute coronary syndrome and elevated lipoprotein(a) levels: a HUYGENS secondary analysis — Yu Kataoka, Peter J. Psaltis, et al. · European Journal of Preventive Cardiology (2025) | TGRS Research Map | TGRS